Consorci Hospital General Universitari de València

Valencia 46016

1 studies enrolling now · 8 studies all time

What they study most

Colorectal Carcinoma Liver Metastases, Diabetes Mellitus, Type 1, Esophageal Squamous Cell Carcinoma, HER2-positive Breast Cancer, Liver Resection, Liver Stiffness, Metastatic Melanoma, NASH - Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis, Primary Biliary Cholangitis

Studies at this site

• Safety of HRX215 in Patients After Minor and Major Liver Resection — Recruiting now
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer — Running, not enrolling
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma — Completed
• A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness — Completed
• Gan & Lee Insulin Glargine Target Type (1) Evaluating Research — Completed
• Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 ) — Completed
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early